Daniel Delorme

2.5k citations

39 papers · 1.6k indexed · h-index 23

Impact in

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Organophosphorus compounds synthesis
Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Chemical Synthesis and Analysis

Papers in ⓘ

Molecular Biology 19
- Histone Deacetylase Inhibitors Research 8
- Protein Degradation and Inhibitors 7
- Epigenetics and DNA Methylation 4
- Chemical Synthesis and Analysis 3
Organic Chemistry 17
- Oxidative Organic Chemistry Reactions 4
- Click Chemistry and Applications 3
- Carbohydrate Chemistry and Synthesis 3

Co-authors: Stephen Hanessian (5 shared papers)Giliane Bouchain (5 shared papers)Jeffrey M. Besterman (9 shared papers)Marielle Fournel (7 shared papers)Marie-Claude Trachy-Bourget (6 shared papers)Serge Beaudoin (1 shared paper)Y. LEBLANC (1 shared paper)Zuomei Li (6 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Tetrahedron Letters (5 papers)Journal of Medicinal Chemistry (5 papers)The Journal of Organic Chemistry (3 papers)Alzheimer s & Dementia (2 papers)
Partner nations: Canada Germany

In The Last Decade

Daniel Delorme

38 papers receiving 1.5k citations

Peers

Countries citing papers authored by Daniel Delorme

Since Specialization

Citations

This map shows the geographic impact of Daniel Delorme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Delorme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Delorme more than expected).

Fields of papers citing papers by Daniel Delorme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Delorme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Delorme. The network helps show where Daniel Delorme may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Delorme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Delorme Line = papers co-authored together Daniel Delorme links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo Molecular Cancer Therapeutics ·Marielle Fournel, Claire Bonfils, Yu Hou, Pu Yan, Marie-Claude Trachy-Bourget, Ann Kalita, Jianhong Liu, Aihua Lu, Nancy Z. Zhou, Marie‐France Robert, Jeffrey Gillespie, Jinru Wang, Hélène Ste-Croix, Jubrail Rahil, Sylvain Lefèbvre, Oscar Moradei, Daniel Delorme, A. Robert MacLeod, Jeffrey M. Besterman, Zuomei Li	2008	271
2	Design and reactivity of topologically unique, chiral phosphonamides. Remarkable diastereofacial selectivity in asymmetric olefination and alkylation Journal of the American Chemical Society ·Stephen Hanessian, Daniel Delorme, Serge Beaudoin, Y. LEBLANC	1984	125
3	Mild cleavage of methoxymethyl (MOM) ethers with trimethylsilyl bromide Tetrahedron Letters ·Stephen Hanessian, Daniel Delorme, Yves Dufresne	1984	96
4	Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors. PubMed ·Marielle Fournel, Marie-Claude Trachy-Bourget, Yan Ping, Ann Kalita, Claire Bonfils, Carole Beaulieu, Sylvie Fréchette, Silvana Leit, Elie Abou-Khalil, Soon-Hyung Woo, Daniel Delorme, A. Robert MacLeod, Jeffrey M. Besterman, Zuomei Li	2002	72
5	Novel Hydroxamate and Anilide Derivatives as Potent Histone Deacetylase Inhibitors: Synthesis and Antiproliferative Evaluation Current Medicinal Chemistry ·Giliane Bouchain, Daniel Delorme	2003	69
6	Linking Bisphosphonates to the Free Amino Groups in Fluoroquinolones: Preparation of Osteotropic Prodrugs for the Prevention of Osteomyelitis Journal of Medicinal Chemistry ·Tom J. Houghton, Kelly S.E. Tanaka, Ting Kang, Evelyne Dietrich, Yanick Lafontaine, Daniel Delorme, Sandra S. Ferreira, Frederic Viens, Francis F. Arhin, Ingrid Sarmiento, Dario Lehoux, Ibtihal Fadhil, Karine Laquerre, Jing Liu, Valérie Ostiguy, Hugo Poirier, Greg Moeck, Thomas Parr, Adel Rafai Far	2008	65
7	Stereoselective reduction of acyclic α-bromo esters Tetrahedron Letters ·Yvan Guindon, Christiane Yoakim, René Lemieux, Luc Boisvert, Daniel Delorme, Jean-François Lavallée	1990	61
8	The asymmetric synthesis of α-chloro α-alkyl and α-methyl α-alkyl phosphonic acids of high enantiomeric purity. Tetrahedron Letters ·Stephen Hanessian, Youssef L. Bennani, Daniel Delorme	1990	59
9	Structurally Simple Trichostatin A-Like Straight Chain Hydroxamates as Potent Histone Deacetylase Inhibitors Journal of Medicinal Chemistry ·Soon Hyung Woo, Sylvie Fréchette, Elie Abou Khalil, Giliane Bouchain, Arkadii Vaisburg, Naomy Bernstein, Oscar Moradei, Silvana Leit, Martin Allan, Marielle Fournel, Marie-Claude Trachy-Bourget, Zuomei Li, Jeffrey M. Besterman, Daniel Delorme	2002	53
10	Design and synthesis of a novel class of histone deacetylase inhibitors Bioorganic & Medicinal Chemistry Letters ·Rico Lavoie, Giliane Bouchain, Sylvie Fréchette, Soon Hyung Woo, Elie Abou Khalil, Silvana Leit, Marielle Fournel, Pu Yan, Marie-Claude Trachy-Bourget, Carole Beaulieu, Zuomei Li, Jeffrey M. Besterman, Daniel Delorme	2001	52
11	Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors Journal of Medicinal Chemistry ·Giliane Bouchain, Silvana Leit, Sylvie Fréchette, Elie Abou Khalil, Rico Lavoie, Oscar Moradei, Soon Hyung Woo, Marielle Fournel, Pu Yan, Ann Kalita, Marie-Claude Trachy-Bourget, Carole Beaulieu, Zuomei Li, Marie‐France Robert, A. Robert MacLeod, Jeffrey M. Besterman, Daniel Delorme	2003	52
12	Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors: Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability Journal of Medicinal Chemistry ·Daniel Delorme, Yves Ducharme, Christine Brideau, Chi‐Chung Chan, Nathalie Chauret, Sylvie Desmarais, Daniel Dubé, Jean‐Pierre Falgueyret, Réjean Fortin, Jocelyne Guay, Pierre Hamel, Tom R. Jones, Carole Lépine, Chun Li, M. McAuliffe, Cyril S. McFarlane, Deborah A. Nicoll‐Griffith, Denis Riendeau, James A. Yergey, Yves Girard	1996	51
13	Stereoselective rardical-mediated reduction and alkylation of α-halo esters Tetrahedron Letters ·Yvan Guindon, Jean-François Lavallée, Luc Boisvert, Catherine Chabot, Daniel Delorme, Christiane Yoakim, Dennis G. Hall, René Lemieux, Bruno Simoneau	1991	48
14	Stereoselective Hydrogen Transfer Reactions Involving Acyclic Radicals. Tandem Substituted Tetrahydrofuran Formation and Stereoselective Reduction: Synthesis of the C17-C22 Subunit of Ionomycin The Journal of Organic Chemistry ·Yvan Guindon, Christiane Yoakim, Vida Gorys, William W. Ogilvie, Daniel Delorme, Jean‐Luc Renaud, Gregory H. Robinson, Jean-François Lavallée, Abdelmalik Slassi	1994	46
15	Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors Bioorganic & Medicinal Chemistry Letters ·Ljubomir Isakovic, Oscar M. Saavedra, David B. Llewellyn, Stephen Claridge, Lijie Zhan, Naomy Bernstein, Arkadii Vaisburg, Nadine H. Elowe, Andrea J. Petschner, Jubrail Rahil, Norman Beaulieu, France Gauthier, A. Robert MacLeod, Daniel Delorme, Jeffrey M. Besterman, Amal Wahhab	2009	44
16	Substituted coumarins as potent 5-lipoxygenase inhibitors Bioorganic & Medicinal Chemistry Letters ·Erich L. Grimm, Christine Brideau, Nathalie Chauret, Chi‐Chung Chan, Daniel Delorme, Yves Ducharme, Diane Ethier, Jean‐Pierre Falgueyret, Richard W. Friesen, Jocelyne Guay, Pierre Hamel, Denis Riendeau, Chantal Soucy‐Breau, Philip Tagari, Yves Girard	2006	44
17	Total synthesis of LTB4 and analogs The Journal of Organic Chemistry ·Yvan Guindon, Daniel Delorme, Cheuk K. Lau, Robert Zamboni	1988	39
18	Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816 Journal of Medicinal Chemistry ·John H. Hutchinson, Denis Riendeau, Christine Brideau, Christine Chan, Daniel Delorme, Duche Denis, Jean‐Pierre Falgueyret, Réjean Fortin, J. Guay	1993	37
19	Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis Bioorganic & Medicinal Chemistry ·Kelly S.E. Tanaka, Tom J. Houghton, Ting Kang, Evelyne Dietrich, Daniel Delorme, Sandra S. Ferreira, Laurence Caron, Frederic Viens, Francis F. Arhin, Ingrid Sarmiento, Dario Lehoux, Ibtihal Fadhil, Karine Laquerre, Jing Liu, Valérie Ostiguy, Hugo Poirier, Greg Moeck, Thomas Parr, Adel Rafai Far	2008	36
20	SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes Bioorganic & Medicinal Chemistry Letters ·Oscar M. Saavedra, Ljubomir Isakovic, David B. Llewellyn, Lijie Zhan, Naomy Bernstein, Stephen Claridge, Franck Raeppel, Arkadii Vaisburg, Nadine H. Elowe, Andrea J. Petschner, Jubrail Rahil, Norman Beaulieu, A. Robert MacLeod, Daniel Delorme, Jeffrey M. Besterman, Amal Wahhab	2009	35

About Daniel Delorme

Daniel Delorme is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Physiology and Pharmaceutical Science, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Protein Degradation and Inhibitors (7 papers), Oxidative Organic Chemistry Reactions (4 papers), Fluorine in Organic Chemistry (4 papers), Epigenetics and DNA Methylation (4 papers), Chemical Synthesis and Analysis (3 papers), Click Chemistry and Applications (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). The work is most often cited by research in Organic Chemistry (812 citations), Molecular Biology (852 citations), Oncology (238 citations), Pharmacology (138 citations) and Pharmaceutical Science (46 citations). Daniel Delorme has collaborated with scholars based in Canada and Germany. Frequent co-authors include Stephen Hanessian, Giliane Bouchain, Jeffrey M. Besterman, Marielle Fournel, Marie-Claude Trachy-Bourget, Serge Beaudoin, Y. LEBLANC, Zuomei Li, A. Robert MacLeod and Yvan Guindon. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Alzheimer s & Dementia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact